Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Franchini

Showing results (391-400 of 749) with videos related to

Pageof 75
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 13, 2015
Fish Intake and Venous Thromboembolism: A Systematic Literature ReviewCamilla Mattiuzzi, Gianfranco Cervellin, Massimo Franchini, et al.
Pediatric Blood & Cancer|February 22, 2007
Rituximab for the treatment of childhood chronic idiopathic thrombocytopenic purpura and hemophilia with inhibitorsMassimo Franchini, Marco Zaffanello, Dino Veneri, et al.
Blood Transfusion = Trasfusione Del Sangue|February 11, 2009
Mesenchymal stem cells: from biology to clinical useMauro Krampera, Massimo Franchini, Giovanni Pizzolo, et al.
Seminars in Thrombosis and Hemostasis|January 5, 2008
Reduced von Willebrand factor-cleaving protease levels in secondary thrombotic microangiopathies and other diseasesMassimo Franchini, Martina Montagnana, Giovanni Targher, et al.
Seminars in Thrombosis and Hemostasis|January 30, 2014
Quality of transfusion products in blood bankingMassimo Franchini, Enrico Capuzzo, Rosalia Turdo, et al.
Journal of Thrombosis and Thrombolysis|October 16, 2012
Acquired FXIII inhibitors: a systematic reviewMassimo Franchini, Francesco Frattini, Silvia Crestani, et al.
Expert Opinion on Pharmacotherapy|September 6, 2012
Haemophilia B: current pharmacotherapy and future directionsMassimo Franchini, Francesco Frattini, Silvia Crestani, et al.
Expert Review of Hematology|November 29, 2024
Novel approaches for preventing COVID-19 infection in immunocompromised patients with hematologic malignanciesShmuel Shoham, Daniele Focosi, Massimo Franchini, et al.
Viruses|February 24, 2024
Sotrovimab: A Review of Its Efficacy against SARS-CoV-2 VariantsDaniele Focosi, Arturo Casadevall, Massimo Franchini, et al.
Haematologica|July 2, 2002
A severe adverse event in an elderly patient undergoing preoperative autologous blood donationMassimo Franchini, Giorgio Gandini, Marzia de Gironcoli, et al.
Pageof 75

Showing results (391-400 of 749) with videos related to

Sort By:
Pageof 75
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 13, 2015
Fish Intake and Venous Thromboembolism: A Systematic Literature ReviewCamilla Mattiuzzi, Gianfranco Cervellin, Massimo Franchini, et al.
Pediatric Blood & Cancer|February 22, 2007
Rituximab for the treatment of childhood chronic idiopathic thrombocytopenic purpura and hemophilia with inhibitorsMassimo Franchini, Marco Zaffanello, Dino Veneri, et al.
Blood Transfusion = Trasfusione Del Sangue|February 11, 2009
Mesenchymal stem cells: from biology to clinical useMauro Krampera, Massimo Franchini, Giovanni Pizzolo, et al.
Seminars in Thrombosis and Hemostasis|January 5, 2008
Reduced von Willebrand factor-cleaving protease levels in secondary thrombotic microangiopathies and other diseasesMassimo Franchini, Martina Montagnana, Giovanni Targher, et al.
Seminars in Thrombosis and Hemostasis|January 30, 2014
Quality of transfusion products in blood bankingMassimo Franchini, Enrico Capuzzo, Rosalia Turdo, et al.
Journal of Thrombosis and Thrombolysis|October 16, 2012
Acquired FXIII inhibitors: a systematic reviewMassimo Franchini, Francesco Frattini, Silvia Crestani, et al.
Expert Opinion on Pharmacotherapy|September 6, 2012
Haemophilia B: current pharmacotherapy and future directionsMassimo Franchini, Francesco Frattini, Silvia Crestani, et al.
Expert Review of Hematology|November 29, 2024
Novel approaches for preventing COVID-19 infection in immunocompromised patients with hematologic malignanciesShmuel Shoham, Daniele Focosi, Massimo Franchini, et al.
Viruses|February 24, 2024
Sotrovimab: A Review of Its Efficacy against SARS-CoV-2 VariantsDaniele Focosi, Arturo Casadevall, Massimo Franchini, et al.
Haematologica|July 2, 2002
A severe adverse event in an elderly patient undergoing preoperative autologous blood donationMassimo Franchini, Giorgio Gandini, Marzia de Gironcoli, et al.
Pageof 75